Treatment gaps in the care of amyotrophic lateral sclerosis in the Philippines: A scoping review

被引:1
作者
Ditan, Iris D. [1 ,2 ]
Turalde, Christian Wilson R. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Philippines Manila, Coll Med, Dept Neurosci, Manila, Philippines
[2] Univ Philippines Manila, Philippine Gen Hosp, Manila, Philippines
[3] Univ Philippines Manila, Coll Med, Dept Physiol, Manila, Philippines
[4] Univ Philippines Manila, Natl Teacher Training Ctr Hlth Profess, Manila, Philippines
[5] Univ Philippines Manila, Dept Physiol, 2nd floor Salcedo Hall,Pedro Gil St, Manila City, National Capita, Philippines
关键词
Amyotrophic lateral sclerosis; Treatment gaps; Philippines;
D O I
10.1016/j.heliyon.2024.e27944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a progressive disease affecting both the upper and lower motor neurons. Much of the management of ALS is supportive with the goal of maximizing patient quality of life. While the Philippines was participative in the "Ice Bucket Challenge" in 2014, it is up for investigation whether substantial changes occurred to improve healthcare for ALS patients. This study aims to evaluate the treatment gaps in the management of ALS in the Philippines through a scoping review. Data on epidemiology, health systems, and pharmacotherapy available regarding ALS in the local setting were synthesized. Nine articles were included. As of July 2023, there were only four indexed studies on ALS from the Philippines. Five of the included articles investigated ALS in Filipino populations but were not authored by Filipinos nor affiliated with Philippine institutions. The available literature showed a distinct lack of local ALS epidemiologic data, as well as limited availability in diagnostic centers, medications, health financing options, and digestible information for Filipinos. The limitations in managing ALS in the country are multifactorial - from political, medical, and social. It is imperative to establish a national database, financing systems, support groups, and accessible diagnostic centers for ALS patients.
引用
收藏
页数:12
相关论文
共 27 条
  • [21] AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSONISM-DEMENTIA ON GUAM, 1945-1972 .1. DESCRIPTIVE EPIDEMIOLOGY
    REED, DM
    BRODY, JA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1975, 101 (04) : 287 - 301
  • [22] Neuroepidemiology of amyotrophic lateral sclerosis: Clues to aetiology and pathogenesis
    Roman, GC
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (02) : 131 - 137
  • [23] Turalde CWR, 2021, ARQ NEURO-PSIQUIAT, V79, P1002, DOI [10.1590/0004-282X-ANP-2019-0464, 10.1590/0004-282x-anp-2019-0464]
  • [24] Statista, 2023, Share of Household Out-Of-Pocket Payment on the Current Health Expenditure in the Philippines from 2014 to 2022
  • [25] Perampanel for amyotrophic lateral sclerosis: A systematic review and meta-analysis
    Turalde, Christian Wilson R.
    Moalong, Kevin Michael C.
    Espiritu, Adrian I.
    Prado, Mario B., Jr.
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (02) : 889 - 897
  • [26] A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
    Weiss, Michael D.
    Macklin, Eric A.
    Simmons, Zachary
    Knox, Angela S.
    Greenblatt, David J.
    Atassi, Nazem
    Graves, Michael
    Parziale, Nicholas
    Salameh, Johnny S.
    Quinn, Colin
    Brown, Robert H.
    Distad, Jane B.
    Trivedi, Jaya
    Shefner, Jeremy M.
    Barohn, Richard J.
    Pestronk, Alan
    Swenson, Andrea
    Cudkowicz, Merit E.
    [J]. NEUROLOGY, 2016, 86 (16) : 1474 - 1481
  • [27] A mechanism for low penetrance in an ALS family with a novel SOD1 deletion
    Zinman, L.
    Liu, H. N.
    Sato, C.
    Wakutani, Y.
    Marvelle, A. F.
    Moreno, D.
    Morrison, K. E.
    Mohlke, K. L.
    Bilbao, J.
    Robertson, J.
    Rogaeva, E.
    [J]. NEUROLOGY, 2009, 72 (13) : 1153 - 1159